4-102631620-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6_ModerateBS1
The NM_005908.4(MANBA):c.*437A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000376 in 414,552 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00088 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000084 ( 1 hom. )
Consequence
MANBA
NM_005908.4 3_prime_UTR
NM_005908.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.519
Genes affected
MANBA (HGNC:6831): (mannosidase beta) This gene encodes a member of the glycosyl hydrolase 2 family. The encoded protein localizes to the lysosome where it is the final exoglycosidase in the pathway for N-linked glycoprotein oligosaccharide catabolism. Mutations in this gene are associated with beta-mannosidosis, a lysosomal storage disease that has a wide spectrum of neurological involvement. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 4-102631620-T-A is Benign according to our data. Variant chr4-102631620-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 347066.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000881 (134/152130) while in subpopulation AFR AF= 0.00287 (119/41480). AF 95% confidence interval is 0.00245. There are 0 homozygotes in gnomad4. There are 62 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MANBA | NM_005908.4 | c.*437A>T | 3_prime_UTR_variant | 17/17 | ENST00000647097.2 | NP_005899.3 | ||
MANBA | XM_047415692.1 | c.*437A>T | 3_prime_UTR_variant | 18/18 | XP_047271648.1 | |||
MANBA | XM_047415693.1 | c.*437A>T | 3_prime_UTR_variant | 18/18 | XP_047271649.1 | |||
MANBA | XM_047415694.1 | c.*437A>T | 3_prime_UTR_variant | 13/13 | XP_047271650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MANBA | ENST00000647097.2 | c.*437A>T | 3_prime_UTR_variant | 17/17 | NM_005908.4 | ENSP00000495247 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000882 AC: 134AN: 152012Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
134
AN:
152012
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000838 AC: 22AN: 262422Hom.: 1 Cov.: 0 AF XY: 0.0000600 AC XY: 8AN XY: 133230
GnomAD4 exome
AF:
AC:
22
AN:
262422
Hom.:
Cov.:
0
AF XY:
AC XY:
8
AN XY:
133230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000881 AC: 134AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.000833 AC XY: 62AN XY: 74386
GnomAD4 genome
AF:
AC:
134
AN:
152130
Hom.:
Cov.:
32
AF XY:
AC XY:
62
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Beta-D-mannosidosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at